retatrutide type 2 diabetes phase 2 trial results 2024 Results: 28.3% Weight Loss Data Retatrutide produces up to 30.3%

As a dual GLP-1/GIP agonist, two receptor systems activate simultaneously

This is legal practice in the US, but Ozempic is not FDA-approved for obesity

Lymphatic drainage sessions typically produce immediate improvements in fluid retention and skin texture, with cumulative benefits over a treatment series

Low blood sugar can develop hours after alcohol is consumed, which becomes risky if it happens during sleep

When the non-mitochondrial oxygen consumption, measured after full inhibition of mitochondrial electron transport chain by antimycin A and rotenone, was subtracted, the routine mitochondrial respiration was increased in the irisin and Ex-4 treated cells

He is also an FMCSA-Certified Medical Examiner conducting DOT physicals and is pursuing advanced certification in Longevity Medicine